Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3
Annals of Neurology · 2024-02 · 95 (2) · 400-406
DOI: 10.1002/ana.26824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 05.12.2023. Verfasst von Jennifer Faber und 38 weiteren Autor:innen. Beteiligte Einrichtung: German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Hauptthemen laut MEDLINE: Machado-Joseph Disease, Cerebellar Ataxia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, NINDS NIH HHS, EU Joint Programme – Neurodegenerative Disease Research.
Abstract (Originalsprache)
Spinocerebellar ataxia type 3/Machado–Joseph disease is the most common autosomal dominant ataxia. In view of the development of targeted therapies, knowledge of early biomarker changes is needed. We analyzed cross‐sectional data of 292 spinocerebellar ataxia type 3/Machado–Joseph disease mutation carriers. Blood concentrations of mutant ATXN3 were high before and after ataxia onset, whereas neurofilament light deviated from normal 13.3 years before onset. Pons and cerebellar white matter volumes decreased and deviated from normal 2.2 years and 0.6 years before ataxia onset. We propose a staging model of spinocerebellar ataxia type 3/Machado–Joseph disease that includes a biomarker stage characterized by objective indicators of neurodegeneration before ataxia onset. ANN NEUROL 2024;95:400–406
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
- Department of Neurology, University Hospital Bonn, Bonn, Germany.
- University of Bonn, Medical Faculty, Institute for Medical Biometry, Informatics, and Epidemiology, Bonn, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
- Institute for Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.
- Center for Neuroscience and Cell Biology (CNC), University of Coimbra, Coimbra, Portugal.
ORCID-Profile: Jennifer Faber, Carlo Wilke, Jeannette Hubener-Schmid, Luís Pereira de Almeida, Gulin Oz, Matthis Synofzik, Heike Jacobi, Kathrin Reetz
Förderung
- Medical Research Council
- NINDS NIH HHS
- EU Joint Programme – Neurodegenerative Disease Research
- National Ataxia Foundation
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Faber, J., Berger, M., Wilke, C., Hubener-Schmid, J., Schaprian, T., Santana, M. M., Grobe-Einsler, M., Onder, D., Koyak, B., Giunti, P., Garcia-Moreno, H., Gonzalez-Robles, C., Lima, M., Raposo, M., Melo, A. R. V., de Almeida, L. P., Silva, P., Pinto, M. M., van de Warrenburg, B. P., …, & Klockgether, T. (2024). Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3. Annals of Neurology, 95(2), 400-406. https://doi.org/10.1002/ana.26824
Vancouver
Faber J, Berger M, Wilke C, Hubener-Schmid J, Schaprian T, Santana MM, et al. Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3. Annals of Neurology. 2024;95(2):400-406. doi:10.1002/ana.26824
BibTeX
@article{Faber2024,
author = {Faber, Jennifer and Berger, Moritz and Wilke, Carlo and Hubener-Schmid, Jeannette and Schaprian, Tamara and Santana, Magda M and Grobe-Einsler, Marcus and Onder, Demet and Koyak, Berkan and Giunti, Paola and Garcia-Moreno, Hector and Gonzalez-Robles, Cristina and Lima, Manuela and Raposo, Mafalda and Melo, Ana Rosa Vieira and de Almeida, Luís Pereira and Silva, Patrick and Pinto, Maria M and van de Warrenburg, Bart P and van Gaalen, Judith and de Vries, Jeroen and Oz, Gulin and Joers, James M and Synofzik, Matthis and Schols, Ludger and Riess, Olaf and Infante, Jon and Manrique, Leire and Timmann, Dagmar and Thieme, Andreas and Jacobi, Heike and Reetz, Kathrin and Dogan, Imis and Onyike, Chiadikaobi and Povazan, Michal and Schmahmann, Jeremy and Ratai, Eva-Maria and Schmid, Matthias and Klockgether, Thomas},
title = {Stage‐Dependent Biomarker Changes in Spinocerebellar Ataxia Type 3},
journal = {Annals of Neurology},
year = {2024},
volume = {95},
number = {2},
pages = {400--406},
doi = {10.1002/ana.26824}
}
EUVIMED